Last reviewed · How we verify
NCT05520073
A Pilot Study To Evaluate the Effects of Lactobacillus Supplements
NA trial testing Lactobacillus plantarum in Feasibility Studies in 30 participants. Completed in 16 December 2022.
19 October 2022
Quick facts
| Lead sponsor | Seoul National University Hospital |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | other |
| Enrollment | 30 |
| Start date | 1 September 2022 |
| Primary completion | 19 October 2022 |
| Estimated completion | 16 December 2022 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
- Lactobacillus plantarum — full drug profile →
- Vitamin C — full drug profile →
Conditions studied
- Feasibility Studies — all drugs for Feasibility Studies →
Sponsor
Seoul National University Hospital
Who can join
Adults 19 to 64, any sex, with Feasibility Studies. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This is a feasibility study to evaluate a decentralized (remote) clinical trial in Korea. In this study, an open-label, randomized, remote clinical trial to evaluate the effects of lactobacillus supplements on alleviating functional constipation symptoms in poor-health volunteers will be conducted.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Feasibility study for a fully decentralized clinical trial in participants with functional constipation symptoms.
Huh KY, Chung WK, Park J, Lee S, et al · · 2023 · cited 8× · PMID 37632169 · DOI 10.1111/cts.13617
Verify or expand the search:
- PubMed search for NCT05520073
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Lactobacillus plantarum
Trials testing the same drug.
- NCT07194200 — Safety and Efficacy of Lactobacillus Plantarum for Psoriasis: A Randomized Double-Blind Placebo-Controlled Trial · Phase 2 · recruiting
- NCT06808061 — Effects of Lactobacillus Plantarum KABP-51 Probiotic on Body Composition, Microbiome and Mood in Healthy Overweight Adul · NA · completed
- NCT05544942 — GCWB1001 Evaluates the Effectiveness and Safety of Respiratory Health · NA · completed
- NCT05483660 — A Clinical Trial on the Efficacy of Gastric Probiotics in the Treatment of Helicobacter Pylori Infection · Phase 2 · unknown
- NCT04461782 — Interventional Study to Evaluate the Effect of the Oral Administration of L.Plantarum on Vaginal Microbiota · NA · completed
Other recruiting trials for Feasibility Studies
Currently open trials in the same condition.
- NCT07295171 — HELP Study - Towards High Throughput and Efficient Long-axial PET With Oral [18F]FDG · NA · recruiting
- NCT07189286 — Preserving Ability Through Virtual Exercise (PAVE) · NA · recruiting
- NCT07187245 — Feasibility of the Reality PAWS Program for Children in Isolation · NA · recruiting
- NCT07105189 — Feasibility of Wireless Continuous Vital Sign Monitoring and Impact on Patients Undergoing Adult Spinal Surgery in a Gen · NA · recruiting
- NCT07170202 — The Increasing Mindfulness Engagement Project · NA · recruiting
Other Seoul National University Hospital trials
Trials by the same sponsor.
- NCT07262944 — EOI Block in Otoplasty With Rib Cartilage Graft · NA · recruiting
- NCT07464210 — Nemtabrutinib, Bortezomib, and Rituximab for WM · Phase 2 · not yet recruiting
- NCT07550803 — Effect of Intraoperative Dexamethasone on Early Postoperative Sleep Quality in Patients Undergoing Nasal Surgery · NA · not yet recruiting
- NCT07522138 — Home-based Self-exercise in Patients With Parkinson's Disease: A Feasibility Study · NA · not yet recruiting
- NCT07476651 — Scout Dose of Resin Microspheres · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05520073 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Seoul National University Hospital
- Last refreshed: 13 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05520073.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing